# DOD Toxic Exposures, Clinical Trial Award

Source: https://welltoldgrants.com/grants/ht9425-23-terp-cta-dod-toxic-exposures-clinical-trial-award/  
Official notice: https://www.grants.gov/search-results-detail/349151

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 3 awards worth $8.8 million in total. Applications closed on October 4, 2023.

| Field | Value |
|---|---|
| Opportunity number | HT9425-23-TERP-CTA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | October 4, 2023 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 3 |
| Total funding | $8.8 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The TERP CTA supports the rapid implementation of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases, or conditions associated with or resulting from military-related toxic exposures. To meet the intent of the award mechanism, applications must address at least one of the FY23 TERP Programmatic Goals and at least one of the FY23 TERP Topic Areas. Proposed projects may range from small proof-of-concept clinical trials (e.g., pilot, first-in-human, phase 0) designed to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. It is anticipated that outcomes from studies funded by this award will follow a clinical development plan that advances the research to U.S. Food and Drug Administration (FDA) device or drug approval and/or establishment of clinical practice guidelines, as applicable. Applications to the TERP CTA mechanism must support a clinical trial and may not be used for animal or other preclinical research studies. The application will be withdrawn if the proposed research is not a clinical trial.

## Questions people ask

### Is HT9425-23-TERP-CTA still open?

No. It closed on October 4, 2023. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DOD Toxic Exposures, Clinical Trial Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DOD Toxic Exposures, Clinical Trial Award?

Closed October 4, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $8.8 million in total across about 3 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.